Cytochrome P450 enzyme complexes and methods of treatment using the same
OwnerArthur Nonomurainventor
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and compositions for balancing electron reduction potentials of formulations in a manner that reduces susceptibility to changes from xenobiotics. The present invention also provides novel compositions of matter based on structuring from a mobile nucleotide integral to its architecture.
Claims28
An isolated enzyme complex comprising P450:FMN, wherein there is a plurality of FMN molecules in said complex.
A dietary supplement composition comprising FMN together with a food product comprising a reductant or an oxidant.
A formulation comprising an oxidant that induces NADPH:cytochrome P450 reductase in animals together with a carrier.
A method of reducing the amount of xenobiotics in an animal, comprising administering to an animal an effective amount of an oxidant for inducing NADPH:cytochrome P450 reductase.
A topical composition comprising an effective amount of an oxidant for inducing NADPH:cytochrome P450 reductase, together with a suitable carrier.
A carbonated beverage comprising FMN or a salt thereof.
Dependencies are inferred from the claim text.